← Back to patent-cliff list
酒石酸罗格列酮
Tier C — Watch / tradeRosilitazone Tartrate
-
Originator
2008
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：PPARγ
Indications (approved)：二型糖尿病
Regional status
US
-
EU
-
China
批准上市
2008-05-04
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Rosilitazone Tartrate?
Approved indications include: 二型糖尿病.
When does the Rosilitazone Tartrate patent expire?
No public expiry year is available for Rosilitazone Tartrate yet; this page updates once verified.
How do I get a quote for Rosilitazone Tartrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24